Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 10, 2023
External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts
M Berbée, C T Muijs, F E M Voncken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 22, 2025
What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?
P M Putora, G Henke, N Beşe, et al.
Critical Reviews in Oncology/Hematology
|
May 27, 2023
The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer
C Aristei, O Kaidar-Person, L Boersma, et al.
Science Signaling
|
August 21, 2014
The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility
Tai Kiuchi, Elena Ortiz-Zapater, James Monypenny, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 10, 2023
External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts
M Berbée, C T Muijs, F E M Voncken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 22, 2025
What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?
P M Putora, G Henke, N Beşe, et al.
Critical Reviews in Oncology/Hematology
|
May 27, 2023
The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer
C Aristei, O Kaidar-Person, L Boersma, et al.
Science Signaling
|
August 21, 2014
The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility
Tai Kiuchi, Elena Ortiz-Zapater, James Monypenny, et al.
Page
of 6